The global genetic testing market size is expected to reach around US$ 15.8 billion by 2030 from US$ 15.8 billion in 2021 and is expected to grow at an impressive double-digit rate of 7.6% from 2021 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global genetic testing market for the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.
The global genetic testing market is primarily driven by the rising prevalence of chronic and genetic diseases and the introduction of innovative testing kits owing to the technological advancements. The rising consumer awareness regarding the availability of advanced diagnostic tests is fueling the demand for the genetic testing. Moreover, growing geriatric population is expected to propel the market growth in the upcoming future. According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 ad this number is expected 2.1 billion by 2050.
We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1389
Why should you invest in this report?
If you are aiming to enter the global genetic testing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for genetic testing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global genetic testing market include:
- Genentech Inc.
- Sorenson Genomics, LLC
- Abbott Molecular
- Bayer Diagnostics
- Biocartis
- BioHelix
- Celera Genomics
- Genomic Health
- HTG Molecular Diagnostics
- PacBio
Market Segmentation:
By Test Type
- Carrier Testing
- Predictive Testing
- Diagnostic Testing
- Prenatal & Newborn Testing
- Nutrigenomics
- Pharmacogenomics
- Others
By Disease
- Cancer
- Alzheimer’s
- Thalassemia
- Cystic Fibrosis
- Huntington’s Disease
- Duchenne Muscular Dystrophy
- Other Diseases
Regional Analysis:
The geographical analysis of the global genetic testing market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global genetic testing Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global genetic testing market in 2030?
- What is the expected CAGR for the genetic testing market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global genetic testing market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Genetic Testing Market
5.1. COVID-19 Landscape: Genetic Testing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Genetic Testing Market, By Test
8.1. Genetic Testing Market, by Test Type, 2021-2030
8.1.1. Carrier Testing
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Predictive Testing
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Diagnostic Testing
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Prenatal & Newborn Testing
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Nutrigenomics
8.1.5.1. Market Revenue and Forecast (2019-2030)
8.1.6. Pharmacogenomics
8.1.6.1. Market Revenue and Forecast (2019-2030)
8.1.7. Others
8.1.7.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Genetic Testing Market, By Disease
9.1. Genetic Testing Market, by Disease, 2021-2030
9.1.1. Cancer
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Alzheimer’s
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Thalassemia
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Cystic Fibrosis
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Huntington’s Disease
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Duchenne Muscular Dystrophy
9.1.6.1. Market Revenue and Forecast (2019-2030)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Genetic Testing Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Test (2019-2030)
10.1.2. Market Revenue and Forecast, by Disease (2019-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Test (2019-2030)
10.1.3.2. Market Revenue and Forecast, by Disease (2019-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Test (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Disease (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Test (2019-2030)
10.2.2. Market Revenue and Forecast, by Disease (2019-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Test (2019-2030)
10.2.3.2. Market Revenue and Forecast, by Disease (2019-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Test (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Disease (2019-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Test (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Disease (2019-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Test (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Disease (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Test (2019-2030)
10.3.2. Market Revenue and Forecast, by Disease (2019-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Test (2019-2030)
10.3.3.2. Market Revenue and Forecast, by Disease (2019-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Test (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Disease (2019-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Test (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Disease (2019-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Test (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Disease (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Test (2019-2030)
10.4.2. Market Revenue and Forecast, by Disease (2019-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Test (2019-2030)
10.4.3.2. Market Revenue and Forecast, by Disease (2019-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Test (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Disease (2019-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Test (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Disease (2019-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Test (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Disease (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Test (2019-2030)
10.5.2. Market Revenue and Forecast, by Disease (2019-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Test (2019-2030)
10.5.3.2. Market Revenue and Forecast, by Disease (2019-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Test (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Disease (2019-2030)
Chapter 11. Company Profiles
11.1. Genentech Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Sorenson Genomics, LLC
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Abbott Molecular
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bayer Diagnostics
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Biocartis
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. BioHelix
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Celera Genomics
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Genomic Health
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. HTG Molecular Diagnostics
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. PacBio
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1389
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments